Riskpilot← Back to searchSign inGet full accessSÆVARSSON HELSE AS
ASActiveOrg 993871354Parkveien 5C, 0350 OsloMedical specialists activities · NACE 8622Est. 20090 employees
Revenue 2025
NOK 234K
EBITDA margin
84.3%
+812% vs 2024
Equity ratio
86.2%
Financial strength
Net profit 2025
NOK 2,5M
-1% vs 2024
| Revenue | NOK 234K | — |
| EBITDA | NOK 197K | +812% |
| Net profit | NOK 2,5M | -1% |
| Total assets | NOK 7,3M | +19% |
| Equity | NOK 6,3M | +32% |
| Employees | 0 | — |
Legal name
SÆVARSSON HELSE AS
Org number
993871354
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
25. mars 2009
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Helserelaterte tjenester, kjøp og salg av aksjer, eiendommer og alt hva herved kommer i forbindelse.
Address
Parkveien 5C, 0350 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 234 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −29 | −29 | −24 | −28 | 197 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −29 | −29 | −24 | −28 | 197 |
| Net financials | 2 162 | 2 257 | 2 318 | 2 586 | 2 326 |
| Profit before tax | 2 133 | 2 228 | 2 294 | 2 558 | 2 523 |
| Tax | 0 | −0 | −0 | 3 | −0 |
| Net profit | 2 132 | 2 228 | 2 294 | 2 555 | 2 523 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 640 | 4 487 | 5 080 | 6 175 | 7 347 |
| Equity | 2 135 | 3 364 | 3 258 | 4 813 | 6 336 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 504 | 1 123 | 1 822 | 1 362 | 1 011 |
| Total debt | 1 504 | 1 123 | 1 822 | 1 362 | 1 011 |
EBITDA margin
84.3%
This company
15.8%
Market median
+434% vs market
20212025
Equity ratio
86.2%
This company
38.2%
Market median
+126% vs market
20212025
Return on equity
39.8%
This company
18.4%
Market median
+116% vs market
20212025
Net profit margin
1078.6%
This company
8.1%
Market median
+13216% vs market
20212025
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
20212025
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
EG Deputy Member | Deputy Member | 2009 |
MB Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2009 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SÆVARSSON HELSE AS 
SENTRUM ØRE NESE HALS ASBoard members of SÆVARSSON HELSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Endre Grønsberg Asperheim | Deputy Member | 0 companies |
| Moeidur Bernhardsdottir | Chief Executive Officer | 0 companies |
| Thorarinn Örn Sævarsson | Chairman | 0 companies |